Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.

The U.S. Senate has launched an investigation into the high price of Novo Nordisk's popular weight loss and diabetes drugs Ozempic and Wegovy in the United States, versus other countries where the drugs are sold.The investigation into the Danish drugmaker was announced by Sen. Bernie Sanders, the Vermont Independent who chairs the Health, Education, Labor and Pensions (HELP) Committee."The scientists at Novo Nordisk deserve great credit for developing these drugs that have the potential to be a game changer ...